Compound Q&A
What regulatory guidelines apply to Gadoxetate sodium (CAS: 135326-22-6)?
Answer
Gadoxetate sodium (CAS: 135326-22-6) is a pharmaceutical agent used in medical imaging. It is subject to various regulatory guidelines including the REACH regulations in the European Union, FDA approval in the United States, and EPA regulations for environmental protection. The substance is classified under GHS (Globally Harmonized System of Classification and Labeling of Chemicals) as a category 2 respiratory sensitizer and category 1B dermal sensitiser.
About
CAS No
135326-22-6
English Name
Gadoxetate sodium
Molecular Formula
C23H28GdN3Na2O11
Molecular Weight
725.71 g/mol
SMILES
CCOC1=CC=C(C=C1)CC(CN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[Gd+3]
InChIKey
SLYTULCOCGSBBJ-FCQHKQNSSA-I
Last Updated: 2025-09-26 14:59
